XMUS:LSE:LSE-Xtrackers MSCI USA Swap UCITS ETF 1C (GBX)

ETF | Others |

Last Closing

USD 12782.5

Change

-263.50 (-2.02)%

Market Cap

N/A

Volume

544.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 636.56B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 259.48B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing XMUS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.60% 15% F 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.60% 15% F 23% F
Trailing 12 Months  
Capital Gain 5.13% 62% D 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.13% 58% F 59% D-
Trailing 5 Years  
Capital Gain 125.92% 88% B+ 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 125.92% 86% B+ 85% B
Average Annual (5 Year Horizon)  
Capital Gain 37.07% 90% A- 91% A-
Dividend Return 37.07% 90% A- 91% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 166.63% 11% F 10% F
Risk Adjusted Return 22.25% 37% F 51% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.